鄢阳 讲师，副主任医师
硕士招生类型：学术型；专业型
硕士招生专业：外科学（泌尿外科）
博士招生类型：无
博士招生专业：无
所在院系：附属第十人民医院
联系方式：**@163.com
课题组链接：
研究方向
主要任职
科研业绩

1.膀胱肿瘤的早期诊断和手术治疗To study the early diagnosis and surgical treatment of bladder tumor.
2.研究膀胱肿瘤患者尿液中的肿瘤标志物。To study tumor markers in urine of bladder tumor patients.
3.前列腺癌的诊断和手术治疗，优化控尿的前列腺根治手术。To study the diagnosis and surgical treatment of prostate cancer and optimize the radical resection of prostate cancer with urine control.
1、上海市泌尿外科质控专家组成员Member of Shanghai Urology expert group
2、上海市社会医学泌尿外科专业委员会委员。Member of Shanghai Urology Professional Committee of Social Medicine
课题：
上海市科委 （20**0） 神经源性膀胱动物模型的构建及特性研究
代表文章：1、Mao S, Zhang J, Guo Y, Zhang Z, Wu Y, Zhang W, Wang L, Geng J, Yan Y, Yao X. Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report. Drug Des Devel Ther. 2019 Jan 11;13:291-300.
2、Guo Y, Cai K, Mao S, Zhang J, Wang L, Zhang Z, Liu M, Zhang W, Wu Y, Yan Y, Yao X.Preoperative C-reactive protein/albumin ratio is a significant predictor of survival in bladder cancer patients after radical cystectomy: a retrospective study.Cancer Manag Res. 2018 Oct 23;10:4789-4804.
3、Yan Y, Li MN, Yang B, Geng J, Zheng JH, Yao XD.Expression of GFRα3 correlates with tumor progression and promotes cell metastasis in urothelial carcinoma. Minerva Urol Nefrol. 2018 Feb;70(1):79-86.
4、Gao Y, Yan Y, Guo J, Zhang Q, Bi D, Wang F, Chang Z, Lu L1, Yao X, Wei Q.HNF 4α downregulation promotes tumor migration and invasion by regulating E cadherin in renal cell carcinoma. Oncol Rep. 2019 Sep;42(3):1066-1074.
5、Shiyu Mao, Yuan Wu, Ruiliang Wang, Yadong Guo, Dexi Bi, Wenchao Ma, Wentao Zhang, Junfeng Zhang, Yang Yan, Xudong Yao. Overexpression of GAS6 Promotes Cell Proliferation and Invasion in Bladder Cancer by Activation of the PI3K/AKT Pathway. Onco Targets Ther.2020;13:4813-4824
6、Yadong Guo, Xiaoliang Jie, Aihong Zhang, Wentao Zhang, Ruiliang Wang, Junfeng Zhang, Shiyu Mao, Yuan Wu, Longsheng Wang, Ziwei Zhang, Yang Yan, Ping Wang, and Xudong Yao. Valuation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-onfined Bladder Cancer. Front Oncol. 2019; 9: 1315.
7、Shiyu Mao, Yuan Wu, Ruiliang Wang, Yang Yan et al. Intraoperative use of single dose of nonsteroidal anti-inflammatory drugs was not associated with cancer recurrence and mortality after bladder cancer surgery: a retrospective study. Ann Palliat Med. 2020;9(1):8-18.